CERo Therapeutics Stock (NASDAQ:CERO)
Previous Close
$0.24
52W Range
$0.06 - $12.80
50D Avg
$0.11
200D Avg
$1.14
Market Cap
$38.79M
Avg Vol (3M)
$63.12M
Beta
-0.46
Div Yield
-
CERO Company Profile
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.